Efficacy and Safety Study of Avastin to Treat Neovascularisation of the Cornea

Inclusion Criteria: inclusion criteria: * Patients with corneal neovascularization whatever the origin * Patient did not receive treatment with topical corticosteroids during the month preceding inclusion. * Patient who has been properly informed and signed consent * Patient aged over 18 * Patient affiliated with a health insurance plan or benefit of such a regime Exclusion Criteria: * Patients who received local or general treatment of concomitant prostaglandin derivatives * Patients with current infection of the cornea or other tissue / organ * Women of childbearing age without contraception * Pregnancy and Lactation * Patient participating in another study * Patient with contact lenses * Patients with uncontrolled hypertension * Patient with a history of stroke, myocardial infarction, angina pectoris, thrombophlebitis, Raynaud's phenomenon. * Patients hypersensitive to the active substance or any excipients * Patients hypersensitive to products of Chinese hamster ovary cells or other recombinant human or humanized antibodies. * Patients with active bacterial eye infections, fungal, parasitic or viral infection (with the exception of herpes)